Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Amylin analysts advise caution amid stock run-up
Posted on March 28, 2012 at 16:59 PM EDT
Amylin Pharmaceuticals analysts are advising investors to proceed with caution given Wednesday’s massive run-up in the stock on a report that Bristol-Meyers had made a bid for the company.
Read More >>
AstraZeneca PLC ADS
Bristol-Myers Squibb Co.
Eli Lilly & Co.
Forest Laboratories, Inc.
GlaxoSmithKline PLC ADS
Merck & Co., Inc.
Novo Nordisk A/S ADS
Takeda Pharmaceutical Co Ltd Sponsored ADR
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here